Pathfinder Cell Therapy (Pathfinder Cell Therapy) Pre-Tax Income : $-1.08 Mil (TTM As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Pathfinder Cell Therapy's pretax income for the three months ended in Sep. 2015 was $-0.29 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2015 was $-1.08 Mil. Pathfinder Cell Therapy's pretax margin was %.

Pathfinder Cell Therapy Pre-Tax Income Historical Data

The historical data trend for Pathfinder Cell Therapy's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Pre-Tax Income Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Pre-Tax Income

Get a 7-Day Free Trial

-1.29

-11.27

-2.16

-1.71

-1.39

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Pre-Tax Income	Get a 7-Day Free Trial															-0.28	-0.29	-0.28	-0.22	-0.29

Competitive Comparison of Pathfinder Cell Therapy's Pre-Tax Income

For the Biotechnology subindustry, Pathfinder Cell Therapy's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pathfinder Cell Therapy's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pathfinder Cell Therapy's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pathfinder Cell Therapy's Pre-Tax Income falls into.

Pathfinder Cell Therapy Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pathfinder Cell Therapy's Pretax Income for the fiscal year that ended in Dec. 2014 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.119	+	0	+	-0.275	+	0	+	2.2204460492503E-16
	=	-1.39

Pathfinder Cell Therapy's Pretax Income for the quarter that ended in Sep. 2015 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.209	+	0	+	-0.08	+	0	+	0
	=	-0.29

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.08 Mil.

Pathfinder Cell Therapy (OTCPK:PFND) Pre-Tax Income Explanation

Pathfinder Cell Therapy's Pretax Margin for the quarter that ended in Sep. 2015 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.289	/	0
	=	%

Pathfinder Cell Therapy Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines